Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.

Always stay updated with the free CMN Newsletter.

Avance Biosciences

Company type: CRO

Main focus: Genomics and molecular biology assays

Company stage: Actively providing services

Diseases: None

Genome-editing tool: N/A

Funding stage: N/A

Location: Houston, Texas, USA


Pipeline: N/A


Avance Biosciences primarily focuses on providing CGMP- and GLP-compliant genomics and molecular biology services. The company offers sensitive and high-throughput amplicon sequencing to accurately quantify on-target editing efficiency and off-target editing events at predicted loci, including chromosome translocation events. They also offer a range of services related to genotyping, gene expression analysis, and other molecular biology techniques for various applications including CRISPR and CAR-T cells.


HashtagAvance Biosciences

Company: Avance Biosciences
Search CRISPR Medicine